(PRESS RELEASE) STOCKHOLM, 7-Jul-2022 — /EuropaWire/ — Skanska (STO: SKA-B), a world leading project development and construction group, has announced a new contract worth EUR 41 million (~ SEK 430 million) with The Hospital District of Southwest Finland for the … Read the full press release
(PRESSEMITTEILUNG) STOCKHOLM, 7-Jul-2022 — /EuropaWire/ — Skanska (STO: SKA-B), ein weltweit führendes Projektentwicklungs- und Bauunternehmen group, hat einen neuen Vertrag im Wert von 41 Millionen Euro (~ 430 Millionen SEK) mit dem Hospital District of Southwest Finland für den Bau … Read the full press release
(PRESS RELEASE) ESPOO, 8-Feb-2022 — /EuropaWire/ — Gasum, a Finnish government-owned energy company, has announced the company will start supplying liquefied natural gas (LNG) and liquefied biogas (LBG) to Sucros Oy, a Finnish sugar company. Sucros, part of Nordzucker AG, … Read the full press release
Posted in Energy, Gas & Oil, Environment, Finland, Food & Beverage, Industrial, News, Technology
Tagged biogas plants, biosludge, carbon neutral, circular economy, CO2 emissions reduction, Finnish sugar company, Gasum, Huittinen, Jussi Urponen, LBG, liquefied biogas, liquefied natural gas, LNG, Lohja, Nordzucker AG, Pori, reduce greenhouse gas emissions, renewable biogas, Säkylä, SoX, Sucros Oy, sugar beet factory, Suomen Sokeri, Tommy Mattila, Turku, wastewater sludge
22-7-2013 — /EuropaWire/ — Neste Oil’s NExBTL renewable diesel, produced from 100% renewable inputs, will be used to generate the electrical power used at the Down By The Laituri Festival in Turku, Finland between July 24 and 28 2013. Down By … Read the full press release
Turku, 30-5-2013 — /europawire.eu/ — Biotie today announced that its partner H.Lundbeck A/S (Lundbeck) has launched Selincro in the United Kingdom. According to the terms of the license agreement between Biotie and Lundbeck for Selincro, Biotie is eligible for a milestone payment … Read the full press release
Posted in Finland, Healthcare, Pharma & Biotech, United Kingdom
Tagged Biotie, Biotie Therapies Corp, detoxification, H.Lundbeck A/S, high drinking risk level, nalmefene, SELINCRO, Timo Veromaa, Turku
Turku, 29-5-2013 — /europawire.eu/ — Biotie Therapies today announced the start of a Phase 2 clinical study evaluating nepicastat (SYN117) in cocaine dependence. The National Institute on Drug Abuse (NIDA) at the US National Institutes of Health is funding the conduct … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
